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Catalytically Active MAP KAP Kinase 2 Structures
in Complex with Staurosporine and ADP Reveal
Differences with the Autoinhibited Enzyme
Mice engineered to be homozygously deficient in MK2
show a reduction in TNF-, interferon-, IL-1, and IL-6
production and an increased rate of survival upon chal-
lenge with LPS, suggesting that this enzyme is a key
component in the inflammatory process and a potential
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Karl Malakian, Jean-Baptiste Telliez, target for anti-inflammatory therapy (Kotlyarov et al.,
1999). Activation of MK2 results in the production ofLih-Ling Lin, Ronald W. Kriz, Jasbir Seehra,
William S. Somers, and Mark L. Stahl cytokines by regulating the translation and or stability
of the encoding mRNAs through the AU-rich elementsDepartment of Biological Chemistry
Wyeth Research of the 3-untranslated regions of the gene (Neininger et
al., 2002). MK2 also phosphorylates the transcription87 Cambridge Park Drive
Cambridge, Massachusetts 02140 factor CREB, as well as leukocyte-specific protein-1 and
heat shock protein 25/27, which are involved in the regu-
lation of actin polymerization (Tan et al., 1996; Lavoie
et al., 1993; Stokoe et al., 1992b; Ben-Levy et al., 1995)Summary
and cell migration (Hedges et al., 1999; Kotlyarov et al.,
2002).MAP KAP kinase 2 (MK2), a Ser/Thr kinase, plays a
crucial role in the inflammatory process. We have de- MK2 is a multidomain protein consisting of an N-ter-
minal proline-rich domain, a catalytic kinase domain, antermined the crystal structures of a catalytically active
C-terminal deletion form of human MK2, residues 41– autoinhibitory domain, and, at the C terminus, a nuclear
export signal (NES) and nuclear localization signal (NLS)364, in complex with staurosporine at 2.7 A˚ and with
ADP at 3.2 A˚, revealing overall structural similarity with (Stokoe et al., 1993; Engel et al., 1998; Ben-Levy et al.,
1998; Engel et al., 1993; Veron et al., 1993). Two isoformsother Ser/Thr kinases. Kinetic analysis reveals that the
Km for ATP is very similar for MK2 41–364 and p38- of human MK2 have been characterized. One isoform
consists of 400 amino acids; the other isoform com-activated MK2 41–400. Conversely, the catalytic rate
and binding for peptide substrate are dramatically re- prises 370 residues and is thought to be a splice variant
missing the C-terminal NLS (Stokoe et al., 1993; Zu et al.,duced in MK2 41–364. However, phosphorylation of
MK2 41–364 by p38 restores the Vmax and Km for peptide 1994; Engel et al., 1998). MK2 is located in the nucleus of
the cell, and, upon binding and phosphorylation by p38,substrate to values comparable to those seen in p38-
activated MK2 41–400, suggesting a mechanism for the MK2 NES becomes functional and both kinases are
cotransported out of the nucleus to the cytoplasm (Ben-regulation of enzyme activity.
Levy et al., 1995, 1998; Engel et al., 1998; Stokoe et al.,
1992a). Interestingly, transport of the MK2/p38 complexIntroduction
does not require catalytically active MK2, as the active
site mutant, D207A, is still transported to the cytoplasmMitogen-activated protein (MAP) kinases are a large and
diverse group of Ser/Thr kinases involved in intracellular (Ben-Levy et al., 1998). Phosphorylation of human MK2
by p38 on residues T222, S272, and T334 is thoughtsignaling pathways. The MAP kinase family can be sepa-
rated into three major subgroups, including the extracel- to activate the enzyme by inducing a conformational
change of the autoinhibitory domain, thus exposing thelular signal-regulated kinases (ERKs), the c-Jun N-ter-
minal kinases (JNKs)/stress-activated protein kinases active site for substrate binding (Ben-Levy et al., 1995;
Engel et al., 1995). Mutations of two autoinhibitory do-(SAPKs), and p38/reactivating kinase (RK). The ERKs
are activated by mitogens and growth factors, whereas main residues, W332A and K326E, in murine MK2 dem-
onstrate an increase in basal activity, and a C-terminalthe JNKs/SAPKs and p38/RK are activated by bacterial
lipopolysaccharide (LPS), interleukin-1 (IL-1), tumor ne- deletion of the autoinhibitory domain renders the enzyme
constitutively active, providing additional evidence for thecrosis factor- (TNF-), and cellular stresses such as heat
role of this domain in the inhibition of MK2 activity (Engelshock, osmotic shock, and UV damage. Exposure of
et al., 1995).cells to these factors results in the increased production
In this study we have solved two crystal structuresof proinflammatory cytokines. Analysis of a specific in-
of a constitutively active C-terminal deletion version ofhibitor of p38 MAP kinase, SB203580, reveals that it
human MK2 (residues 41–364), one in complex with ADPinhibits LPS-induced cytokine synthesis in human
and the other with the broad-spectrum kinase inhibitormonocytes, thus indicating that p38 is the MAP kinase
staurosporine. The overall fold of this structure of MK2responsible for stress-induced cytokine production (Lee
is very similar to the structures of other protein kinases.et al., 1994). SB203580 also prevents the activation of
It is bilobal, consisting of an N-terminal domain with aMAP kinase-activated protein kinase 2 (MK2), suggesting
five-stranded  sheet and a conserved  helix and athat this kinase is activated by p38 (Cuenda et al., 1995).
larger C-terminal domain containing largely  helices.
cAMP-dependent protein kinase (PKA) (Zheng et al.,*Correspondence: kunderwood@wyeth.com (K.W.U.), parrisk@
1993), Ca2/calmodulin-dependent protein kinasewyeth.com (K.D.P.)
1These authors contributed equally to this work. (cAMK) (Goldberg et al., 1996), and Titin (Mayans et al.,
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Figure 1. Sequence Alignment of MK2, MK3,
and MK5
Residues highlighted in red are identical; resi-
dues boxed in black designate the GXGXXG
motif; the catalytic RD residues are boxed in
green; residues boxed in blue designate the
bipartite nuclear localization sequence; the
activation loop residues are underlined in
purple; the residues that are phosphorylated
are denoted with orange stars. The second-
ary structure elements of MK2 41–364 are
overlaid on the sequence, with the dark blue
arrows and green cylinders representing the
 strands and  helices, respectively. The
secondary elements of the MK2 47–400 struc-
ture are also overlaid, with the light blue
arrows and purple cylinders representing the
 strands and  helices.
1998) are protein kinases that are structurally related to Results and Discussion
MK2. However, MK2 is distinct from these other kinases
in that the structure of the inactive form of MK2 reveals Alignment of Homologs
MAP KAP kinase 2 (MK2) is an enzyme that belongs to athat the nucleotide binding site is not sterically blocked
(Meng et al., 2002). Analysis of these structures will aid in family of MAP kinase-activated protein kinases. Human
members of this family include MK2, MK3, and MK5the understanding of the regulatory mechanism of MK2.
Crystal Structures of Catalytically Active MK2
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Table 1. Kinetic Analysis of MK2
Construct p38a Apparent Km ATPb (M) Apparent Km LSP-1c (M) Vmaxd (mol/min/mg)
41–400  ND ND No activity
41–400  7.0  0.7 13  1 8.9  0.1
41–364  15  1.5 584  50 0.076  0.004
41–364  ND 20  2 11  14
a For activation, p38 (1.25 g/ml), MK2 (200 g/mL), and ATP (500 M) were incubated for 1–2 hr at 25oC.
b,c,d See Experimental Procedures.
(McLaughlin et al., 1996; Ni et al., 1998). These proteins domain, binds ATP normally, but peptide substrate bind-
ing has been affected dramatically. However, when MK2are highly homologous (Figure 1), and, in addition, all
have been shown to be activated by the MAP kinase 41–364 is phosphorylated by p38, the Vmax of the enzyme
is greatly increased, to 11 mol/min/mg, which is com-p38, although, to date, the only well-studied enzyme is
MK2 (Clifton et al., 1996; Ni et al., 1998). MK2 is phos- parable to the Vmax of p38-activated MK2 41–400, 8.9
mol/min/mg. Phosphorylation of MK2 41–364 also al-phorylated on T222, S272, and T334 by p38 and has a
putative autophosphorylation site at T338 (Ben-Levy et ters the Km for peptide substrate, such that the Km de-
creases from 584 M to 20 M, similar to the Km ob-al., 1995). All four of the phosphorylation sites are con-
served in MK3, but only T222 is present in MK5. All of served in activated MK2 41–400. These data suggest
that, for optimal substrate binding and activity, MK2the isozymes have the ATP binding site motif GXGXXG
(residues 71–76 in MK2), but only MK2 and MK3 have must be phosphorylated. Clearly, phosphorylation of
key residues within the autoinhibitory C-terminal  helixthe bipartite nuclear localization signal KKIEDDASN
PLLLKRRKK (residues 373–389 in MK2). The putative and T222 in the activation segment induce conforma-
tional changes in the enzyme that allow highly efficientactivation segment is highly conserved in all three iso-
zymes (residues 207–233 in MK2), including the con- binding of peptide substrate.
served motifs found to flank the activation segments of
many kinases, DFG, and APE, with the latter being APQ
Structure Determinationin MK5 (Johnson et al., 1996). Interestingly, the conserved
The crystal structure of SeMet-labeled MK2 inhibited byp38 phosphorylation site, T222, is in the activation seg-
staurosporine (Figure 2) was solved by multiple-wave-ment. MK2 and MK3 contain an N-terminal proline-rich
length anomalous dispersion (MAD) (Hendrickson,domain, which is absent in MK5, and the C-terminal exten-
1991). Experimental phases were determined at 3.1 A˚,sion thought to contain the autoinhibitory domain in MK2
modified by solvent flattening and noncrystallographicis elongated in MK5. Overall, MK2 shares 75% identity
with MK3 and 42% identity with MK5.
Analysis of Protein Constructs
MK2 is a 400-amino acid protein consisting of five do-
mains, an N-terminal proline-rich domain, a kinase cata-
lytic domain, a C-terminal kinase autoinhibitory domain,
a nuclear export signal, and a nuclear localization signal,
which is also the postulated site for p38 binding (Tanoue
et al., 2000). After analyzing a large number of constructs
for expression of MK2 in E. coli, we found that deleting
the first 40 residues of the proline-rich domain greatly
enhanced the expression levels and solubility of the
enzyme. Additional analysis of various C-terminal dele-
tions yielded evidence that the best crystals were ob-
tained from protein ending with residue 364. MK2 41–
364, a constitutively active form of the enzyme in which
a portion of the C-terminal autoinhibitory domain was
removed, was purified and produced crystals that dif-
fracted to 2.7 A˚.
As shown in Table 1, the Km for ATP is very similar
for MK2 41–364 and p38-activated MK2 41–400, 7 M
versus 15 M, respectively. However, binding of the
peptide substrate, leukocyte-specific protein 1, to MK2
41–364 is more than 40-fold weaker than to the p38-
activated MK2 41–400, 584M versus13M Km. In addi- Figure 2. Ribbons Representation of MK2 41–364 in Complex with
tion, the Vmax for MK2 41–364 is also much lower than Staurosporine
that for the p38-activated MK2 41–400 (0.076 versus 8.9 Helices, blue; 3-10 turns, dark blue; strands, green; autoinhibitory
mol/min/mg, respectively). These data indicate that domain, red. The secondary structure elements are labeled as in
Figure 1. The figure was generated with Ribbons (Carson, 1997).MK2 41–364, which lacks a portion of the autoinhibitory
Structure
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Although the overall structure of the catalytic domain
is highly conserved in many protein kinases, the mecha-
nisms of regulation are quite diverse and, in some cases,
require dramatic conformational changes (Huse and Ku-
riyan, 2002). The N-terminal and C-terminal lobes of
many protein kinases are connected by a flexible hinge
(residues 142–145; DGGE in MK2); thus, the relative po-
sitions of the domains determine whether the kinase is
in the “open,” or inactive state, versus the “closed,” or
active conformation (Huse and Kuriyan, 2002). MK2 can
be classified as an “RD” kinase, as the catalytic aspar-
tate, D186, is immediately preceded by an arginine,
R185. Activation of a number of RD kinases requires
phosphorylation on one or more threonine, serine, or
tyrosine residues within the activation segment. Activa-
tion of MK2 requires phosphorylation, by p38, of the
activation segment residue T222.
Three protein kinases closely related to MK2, both
by structure and shared regulatory mechanisms, are
cAMP-dependent protein kinase (PKA) (Zheng et al.,
1993), Ca2/calmodulin-dependent protein kinase
(cAMK) (Goldberg et al., 1996), and Titin (Mayans et al.,
1998) (Figure 4). All are Ser/Thr kinases and all require
phosphorylation of a residue within the activation seg-
ment for activation of the kinase. Like MK2, all share an
additional level of negative regulation by either a C-ter-
minal autoinhibitory domain or a regulatory subunit. Al-
though PKA lacks an autoinhibitory domain, a bound
regulatory subunit maintains the kinase in an inactive
conformation. Activation of PKA requires binding of an
allosteric regulator, cAMP, to the regulatory subunit,
resulting in a conformation change and release of theFigure 3. Electron Density Maps of Stauroporine and ADP
catalytically active kinase subunit. cAMK is maintained(A) The experimental map generated with MAD phases for the stau-
in an inactive conformation by a C-terminal autoinhibi-rosporine moiety contoured at 1 	.
(B) An unbiased 2Fo  Fc electron density map around ADP in the tory domain that blocks both substrate and ATP binding.
active site contoured at 1 	. Activation of cAMK requires Ca2/calmodulin binding,
which is thought to induce a conformation change re-
sulting in the displacement of the autoinhibitory domain
symmetry averaging, and extended to 2.7 A˚. The experi- from the peptide and ATP binding sites. Titin also con-
mental map for staurosporine is shown in Figure 3A. tains a C-terminal autoinhibitory domain that sterically
The final model was refined to a crystallographic R factor blocks both substrate and ATP binding. Titin activation
of 23.9%, with an Rfree of 27.4% (Tables 2 and 3). With also requires Ca2/calmodulin binding, which is also
this structure of MK2, the structure of ADP bound to thought to induce a conformation change resulting in
MK2 was solved by molecular replacement. The final the displacement of the autoinhibitory domain from the
model for this costructure was refined to a crystallo- peptide and ATP binding sites. The recently published
graphic R factor of 25.9% and an Rfree of 29.2%. The structure of the autoinhibited, inactive form of MK2 47–400
electron density for ADP is shown in Figure 3B. reveals a unique mechanism of kinase regulation (Meng
et al., 2002). The C-terminal autoinhibitory  helix extends
Analysis of MK2 Structures and Comparison along the entire surface of one face of the C-terminal lobe
with Other Kinases adjacent to the active site and binds, hypothetically, as
The MK2 kinase core domain contains an overall fold a pseudosubstrate (Figure 4B). D366 acts as a phos-
that is very similar to the structures of other protein phothreonine mimetic by coordinating with the basic
kinases (Figure 4). It is bilobal, consisting of a smaller residues R185 and K212 within the active site of the
N-terminal domain that is largely  sheet and a larger enzyme. This “pseudosubstrate” region is thought to
C-terminal domain dominated by  helices. MK2 shares be positioned in a manner that would effectively block
two structural features within the N-terminal lobe that binding of both protein and peptide substrates.
have been shown to be important in the regulation of The N-terminal lobe of the kinase domain in the inac-
many protein kinases (Huse and Kuriyan, 2002). These tive MK2 structure has significant structural differences
structural elements are the highly conserved C helix compared to the catalytically active MK2 structures pre-
(residues 99–113) and the 1-2 loop (residues 13–32), sented here (Figure 4A and 4B). First, the C helix is
which has been termed the phosphate binding loop, or one full turn shorter in the autoinhibited structure than
“P loop.” This P loop contains the highly conserved ATP in the structures we present here. Additionally, the 1
strand, which is present in our structures as well as inbinding motif GXGXXG (Figure 2).
Crystal Structures of Catalytically Active MK2
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Table 2. Statistics for Data Collection and Phase Determination
MK2-Staurosporine MK2-Staurosporine MK2-ADP
Remote Peak Inflection SeMet Native
Wavelength (A˚) 
3  0.95666 
1  0.97926 
2  0.97955 1.1 1.0
Resolution range (A˚) 50–3.1 50–3.1 50–3.1 50–2.7 25–3.1
Rmergea (%) 6.7 (49.2) 6.6 (37.7) 6.0 (37.9) 4.7 (48.1) 5.5 (63.1)
Completeness (%) 99.6 (99.4) 100 (100) 100 (100) 100 (100) 99.3 (100.0)
Total reflections 255,756 427,587 449,393 215,726 90,852
Unique reflections 42,015 42,754 42,927 52,352 12,997
I/	(I) 10.8 (1.7) 16.2 (3.4) 18.0 (3.6) 20.2 (1.6) 34.9 (3.3)
f(e)b 2.95 4.60 7.21
f″(e) 3.70 6.44 1.81
MAD Phasing Statistics for MK2-Staurosporine
Resolution limits (A) 6.92 5.24 4.62 4.00 3.70 3.46 3.27 3.10 Overall
Phasing powerc

3 anomalous 3.36 2.08 1.72 1.07 0.82 0.68 0.55 0.52 1.08

1 isomorphous 0 0 0 0 0 0 0 0 0

1 anomalous 5.48 4.36 3.58 2.57 1.99 1.64 1.34 1.12 2.39

2 isomorphous 2.72 2.35 1.96 1.59 1.35 1.14 0.93 0.80 1.57

2 anomalous 2.99 1.67 1.33 0.83 0.62 0.53 0.40 0.36 0.80
Mean FOMd 0.85 0.75 0.70 0.60 0.55 0.48 0.42 0.39 0.59
a Rmerge  |Ih  Ih|/Ih, where Ih is the average intensity over symmetry equivalents. Numbers in parentheses reflect statistics for the
last shell.
b f and f″ reported values were refined by SHARP.
c Phasing power  |Fh|/|||FPHobs|  |FPHcalc||, where Fh is the calculated heavy atom structure-factor amplitude.
d Figure of merit  P()eia/|P()|, where  is the phase and P() is the phase probability distribution.
the majority of other kinases, is replaced by an  helix The C-terminal lobe contains another important regu-
latory feature, the MK2 activation segment (residuesin the autoinhibited MK2 stucture. It is interesting to
speculate that this significant conformational change in 207–233), a fragment of which extends outward from
the surface of the catalytic domain into solvent as partthe structure of the N-terminal lobe may be part of the
MK2 activation process, but another possibility as to the of a loop terminating at residue 239. In the structure
of the autoinhibited form of MK2, this portion of thedifference in the structures may be due to the conditions
used for crystallization and heavy-atom derivatization. activation segment that extends away from the core is
completely disordered (Meng et al., 2002). In our struc-Meng et al. generated crystals with P1 symmetry con-
taining six molecules per asymmetric unit. Upon soaking tures, the conformation of this loop is partially stabilized
by interactions with the C-terminal domain of a symme-a single crystal in a mercury compound overnight, the
crystal symmetry shifted to R3, containing two molecules try-related molecule, as electron density was observed
for all residues except 216–226. Included in this unob-per asymmetric unit. The authors solved the structure us-
ing a data set collected from the mercury-modified crystal. served section is T222, which is one of the p38 phos-
phorylation sites. These structural data suggest that theSince there are four cysteines in the N-terminal lobe (98,
114, 133, and 140) and each has been derivatized by activation segment in unphosphorylated MK2 is highly
dynamic and solvent accessible.the addition of mercury, it is conceivable that the binding
of these mercury compounds has led to a disruption of As discussed previously, MK2 41–364 is a constitu-
tively active truncated version of the enzyme that doesthe five-stranded  sheet and a conformational shift of
the 1 strand to an  helix. However, the answer to this not contain the complete C-terminal autoinhibitory se-
quence. Of the four MK2 structures in the asymmetricquestion requires further structural studies.
Table 3. Refinement Statistics
Model Refinement MK2-Staurosporine MK2-ADP
Maximum resolution (A˚) 2.7 3.2
Rworka (%) 23.9 25.9
Rfree (%) 27.4 29.2
B value (A˚3) 29.5 86.4
Rms deviations from ideal geometry
Bonds (A˚) 0.018 0.022
Angles () 2.36 1.65
Water molecules 43 0
Ions 2 sulfate none
a Rwork  ||Fobs|  |Fcalc|/|Fobs|. Rfree is equivalent to Rwork, except that it is calculated for a randomly chosen 5% of reflections omitted from
the refinement process.
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Figure 4. Comparison of Ser/Thr Kinases
Ribbons representation of (A) MK2 41–364, (B) MK2 47–400 (Protein Data Bank ID 1KWP), (C) titan kinase (1TKI), (D) camp-dependent kinase
(1ATP), and (E) Ca2/calmodulin-dependent kinase (1A06). Each structure is depicted in approximately the same orientation; autoinhibitory
domain, red. The figures were generated with Ribbons (Carson, 1997).
unit in the complex with staurosporine, C-terminal resi- lated state, is catalytically active and shows normal
binding of ATP. However, the Km for LSP-1 peptide sub-dues 345–364 are disordered in three, but only residues
358–364 are disordered in the fourth. The additional strate is 45-fold higher and the Vmax is 100-fold lower
than those for p38 phosphorylated MK2 41–400 (seeresidues ordered in the latter structure are in contact
with a symmetry-related molecule. The structure of ADP Table 1). Yet, when MK2 41–364 is phosphorylated by
p38, it exhibits virtually identical peptide substrate bind-bound to MK2 is most like the former copies of MK2 with
staurosporine. The symmetry interactions that appear to ing and catalytic rates to phosphorylated MK2 41-400.
These data suggest that, when p38 phosphorylates MK2stabilize residues 346–357 are not present, and, thus,
the entire autoinhibitory domain is disordered in the 41–400, key residues on the autoinhibitory C-terminal
helix and residue T222 of the activation segment shiftstructure with ADP. By comparison with the autoinhib-
ited structure, MK2 41–364 contains all of the residues the equilibrium of the pseudosubstrate region from a
bound to an unbound state. The activation segmentthat comprise the autoinhibitory domain  helix. How-
ever, in our structures, this autoinhibitory helix does not equilibrium is shifted from a highly dynamic state, as
observed in the MK2 structures presented here and else-occupy the same location in the C-terminal lobe (Figure
4A and 4B). Instead, it is displaced to one side and is where (Meng et al., 2002), to a more stable bound state,
required for efficient binding of peptide substrate anddisordered after two turns. The location from which the
autoinhibitory helix was displaced is now occupied by a high catalytic rate. Constitutively active MK2 41–364,
however, lacks key residues within the pseudosubstratethe loop containing the activation segment from a sym-
metry-related molecule. The significance of the move- region, and, as observed in the structures presented
here, most of the autoinhibitory C-terminal helix is disor-ment of the autoinhibitory helix and the location of the
activation loop cannot be readily deduced from the dered and probably highly mobile, thus allowing a lower
level of peptide substrate binding and catalysis. Phos-structures we report here and that of the full-length
autoinhibited enzyme. phorylation of MK2 41–364 by p38 restores full enzy-
matic activity, presumably, as described above, by shift-The MK2 structures presented here are of unphos-
phorylated enzyme. MK2 41–364, in the unphosphory- ing the equilibrium of the phosphorylated activation
Crystal Structures of Catalytically Active MK2
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segment to the bound state, allowing efficient binding
of peptide substrate. These data also clearly show that
residues 365–400 are not required for full catalytic activ-
ity in vitro.
Structural Analysis of the ADP
and Staurosporine Costructures
The ATP binding site of protein kinases is located in a
deep cleft between the N-terminal and C-terminal lobes
of the catalytic domain. The 1 and 2 strands in the
N-terminal lobe constitute the P loop, which contains a
glycine-rich motif, GXGXXG, that is highly conserved in
all protein kinases. The conserved glycines confer two
important structural properties to the P loop, the lack
of side chains, which allow loop backbone amides to
interact with ATP phosphates without steric hindrance,
and backbone flexibility, which allows the P loop to Figure 5. Superimposition of the MK2 41–364 Costructure with
adopt multiple conformations. Conformational flexibility Staurosporine onto that of the Costructure of MK2 41–364 with ADP
of the P loop is an important factor in the regulation of The catalytically important residues are labeled. MK2 41–364 is in
many protein kinases. The structure of the MK2 P loop, red when bound to staurosporine (purple) and in cyan when bound
to ADP (blue). This figure was created using Ribbons (Carson, 1997).within the context of a five-stranded  sheet, and the
spatial relationship of the C helix are consistent with
the structures of many protein kinases and also consti-
tute an important part of the kinase active site. As observed in many other RD kinases, including PKA,
that require phosphorylation of a threonine residueA number of catalytic residues conserved in all protein
kinases are spatially oriented to allow efficient transfer within the activation segment for activation and efficient
catalysis, two basic residues, R165 and K189 in PKA,of phosphate from ATP to a protein substrate. As one
of the products of the reaction, adenosine-5-diphos- are required for coordination and charge neutralization of
the phosphoryl threonine. These residues are also spatiallyphate is an efficient probe for these interactions. The
interactions between ADP and MK2 in the structure we conserved in the MK2 structures (R185 and K212).
Comparison of the MK2 structures cocrystallized withhave determined are very similar to those observed in
other kinases in complex with ADP or ATP mimics. Spe- ADP and staurosporine show that the most significant
difference lies in the  sheet containing the GKGINGcifically, the adenine ring is buried in the protein, with
hydrophilic interactions with the L141 main chain nitro- (71–76) loop (Figure 5). This loop, between  strands 1
and 2, and the loop on the other side of  strand 2 thatgen and the E139 main chain oxygen. The phosphate
groups are positioned adjacent to the P loop and have connects to  strand 3 (residues 83–88) move exten-
sively as a result of staurosporine binding deeper intoionic interactions with N191, D207, K93, and I74. Al-
though magnesium was present in the crystallization the ATP binding pocket. The residue at the center of
the loop, I74, moves 4.2 A˚ closer to the activation seg-media, no discernible electron density was found that
could be identified as the magnesium ion. ment when bound with staurosporine than when bound
with ADP. Conversely, in the structure with ADP, T86,The binary complex structure of MK2 41–364 and
staurosporine is very similar to the ternary complex found in the loop between  strand 2 and 3, moves
closer to the protein core by 2.5 A˚ than in the structurestructure of PKA, PKI inhibitor peptide, and stauro-
sporine (Prade et al., 1997) and thus forms the basis for with staurosporine. This coupled movement of the loops
connecting strands 1, 2, and 3 allows the structural in-a comparative analysis of the MK2 and PKA active sites.
The analysis revealed that all active site residues dis- tegrity of the  sheet to remain while moving to accom-
modate different molecules in the active site.cussed below are spatially conserved. R185 and D186
(R165 and D166 in PKA) are catalytic loop residues that Staurosporine binds to the ATP binding pocket of
MK2 in a manner similar to that observed in other kinasesare invariant in all RD kinases. The catalytic aspartate,
D186, is thought to act as a base to remove a proton from (Protein Data Bank codes 1AQ1 [CDK2], 1BYG [SRC],
1QPD and 1QPJ [LCK], and 1STC [cAMP]). The pyrrolidi-the protein substrate hydroxyl group. The phosphates of
ATP are positioned for hydrolysis by interactions with none moiety makes two potential hydrogen bonds, one
to the main chain carbonyl oxygen of E139 and the otherbackbone amide protons in the P loop and by ionic
interactions with K93 (K72 in PKA), which is positioned to the main chain nitrogen of L141. The amino group of
staurosporine interacts with the carbonyl oxygen ofand stabilized properly by E104 (E91 from PKA), a resi-
due from the C helix. This ion pair interaction between E190 and makes a potential hydrogen bond to gluta-
mate. The remaining interactions inside the active siteK93 and E104 is one of the criteria used to judge whether
a kinase is in the active or inactive conformation (Huse are van der Waal-type interactions. The bulk of the amino
acids that make up the lining of the ATP binding siteand Kuriyan, 2002). This interaction as well as the inter-
action of K93 with the  and  phosphates of ADP indi- between these structures differ, leading to cavities and
protrusions in the active site that differ among thesecates that the structures we report here are of MK2 in
its active conformation (Figure 5). proteins, suggesting that the design of ATP binding site
Structure
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and DNase. Cells were lysed by four passages through a Microflu-inhibitors is a possibility. Similar analyses of the ADP/
idics microfluidizer. The lysate was collected and centrifuged atMK2 costructure compared to 1B38 and 1HCK (CDK2),
20,000  g for 30 min. The supernatant was applied to a Poros HQ1CSN (Casein), 1GOL (ERK-2), and 1PHK (phosphony-
column (Applied Biosystems). The flow-through was loaded onto a
lase) show a similar pattern of depressions and ex- Poros HS column (Applied Biosystems), and the bound protein was
trusions in the lining of the ATP binding pocket. The eluted with a gradient of Buffer A plus 1 M NaCl. Ammonium sulfate
to 0.8 M was added to the peak fraction, and the protein was loadedconservation of several of these features supports the
onto a polypropyl aspartamide column (Nest Group) equilibratedhypothesis that ATP binding site-specific compounds
with Buffer B (50 mM HEPES [pH 7.5], 10 mM DTT, and 0.8 Mcan be developed. Specifically, the pocket leading to
ammonium sulfate). The protein was eluted with a gradient, and theH108 in MK2 has no homolog in any of the structures
peak fraction was concentrated in a Millipore Ultrafree concentrator.
listed above. The protein was applied to a Superdex 200 column (Amersham
Pharmacia Biotech) equilibrated with 20 mM HEPES (pH 7.5), 200
mM NaCl, and 10 mM DTT. Protein purity was 95%.Biological Implications
Cells exposed to heat shock, cytokines (TNF and IL-1),
or ultraviolet light display an increase in p38 MAP kinase Kinetic Analysis
Materialsactivity due to phosphorylation by the upstream kinases
ATP, ADP, phosphoenolpyruvate (PEP), NADH, and pyruvate kinase/MKK3 and MKK6. p38 in turn phosphorylates a variety
lactate dehydrogenase enzymes were purchased from Sigmaof substrates, including the transcription factors ATF-2
Chemical (St. Louis). Activated p38 MAP kinase was purchased fromand CHOP-1, and other kinases, such as MK2 and MK3.
Upstate Biotech (Lake Placid, NY). LSP-1 peptide (RTPKLARQA
The p38/MK2 signal transduction cascade plays a piv- SIELPSM) was purchased from AnaSpec (San Jose, CA).
otal role in the production of proinflammatory cytokines. Activation of MK2 Constructs
The MK2 constructs 41–400 and 41–364 were activated by the phos-Mice homozygously deficient in MK2 show a reduction
phorylation of the constructs by p38 MAP kinase. The activationin TNF, IL-1, IL-6, and IFN- synthesis and an increased
was done in 20 mM HEPES (pH 7.5), 10 mM MgCl2, 2 mM DTT, 0.50rate of survival upon exposure to LPS compared to that
mM ATP, 0.2 mg/ml MK2, and 0.125 g activated p38. The reactionin wild-type mice (Kotlyarov et al., 1999). MK2 controls
was incubated at 25C for 1–2 hr and then placed on ice to be used
the synthesis of cytokines by regulating the translation for kinetic analysis.
and/or stability of the encoding mRNAs through the AU- Kinase Kinetics
The rate of MK2 was characterized in 20 mM HEPES (pH 7.5), 10rich elements of the 3-untranslated regions of the gene
mM MgCl2, 2 mM DTT, and 100 mM NaCl. The kinetics was followed(Neininger et al., 2002). These data indicate that MK2 is
by linking the turnover of ATP to the turnover of NADH to NAD. Thisa vitally important enzyme in inflammatory-based dis-
was followed spectrophotometrically at 340 nm. The continuouseases and is a target for anti-inflammatory drug design.
assay contained 20 units pyruvate kinase, 30 units lactate dehydro-
In this study we present the structures of a catalyti- genase, 0.25 mM NADH, 2 mM PEP, and 1.6–8.0 g/ml MK2. For
cally active MK2 41–364 in complex with ADP and stau- determining the apparent Km for ATP, the ATP concentration was
varied from 0.005 to 0.25 mM, while the peptide was held constantrosporine. From these structures, as well as the previous
at 0.2 mM for activated MK2 or at 1.0 mM for the constitutivelystructure of the inactive enzyme 47–400 (Meng et al.,
active form of MK2 (41–364). For determining the apparent Km for2002), we observe that MK2 is regulated quite differently
LSP-1, the LSP-1 concentration was varied from 0.01 to 0.5 mM,from other kinases that have a similar fold. Specifically,
while ATP was held constant at 2 mM. The kinetic analysis was
the autoinhibitory domain of MK2 does not block the carried out in a 96-well plate at 25C, on a Molecular Devices spec-
nucleotide binding site and phosphorylation of the resi- trophotometer.
Substrate Kineticsdues in the activation segment and C-terminal autoin-
Peptide LSP, based on the protein substrate of MK2 lymphocyte/hibitory domain is necessary for optimal binding of the
leukocyte-specific protein, was used for the investigation of thesubstrate and activity of the enzyme. From this work we
kinetic mechanism for the enzyme MK2. Data was fit to Equation 1will have an important tool for designing inhibitors to MK2.
for normal Michaelis-Menten kinetics.
Experimental Procedures v  Vmax [S]/Km  [S] (1)
Cloning and Expression of MK2
where [S] is the substrate, Vmax is the maximum enzyme velocity,The MAP KAP kinase 2 gene was PCR cloned into the NcoI and
and Km is the Michaelis constant.XhoI sites of pET16b (Novagen) with Hot tub polymerase (Amersham
Pharmacia Biotech). The expressed protein contains residues 41–
364, excluding the N-terminal proline-rich sequence. To produce Crystallization
selenomethionine-labeled MK2, we expressed the protein in The selenomethionine-labeled protein was concentrated to 5 mg/
BL21(DE3) (Novagen) E. coli at 25C. Precultures were grown in ml according to the Bradford method (Bradford, 1976) in a solution
shake flasks in LeMaster media supplemented with L-methionine, containing 20 mM HEPES (pH 7.5), 200 mM NaCl, 10 mM DTT, and
and expression cultures were grown in LeMaster media supple- 5 mM MgCl2. Prior to crystallization, staurosporine (0.375 mM) was
mented with L-selenomethionine that was replenished upon culture added from a DMSO stock. Diffraction-quality conical crystals were
induction. Cultures were induced with 0.5 mM IPTG for four hours. obtained at 18C from 2 M ammonium sulfate, 100 mM HEPES (pH
Unlabeled MK2 was also expressed in E. coli BL21 (DE3). The culture 7.5), and 2% PEG 400. These crystals, which appeared in 7–10 days,
was induced with 0.5 mM IPTG and cells were harvested 4 hr postin- belong to space group P63, with cell dimensions of a b 160.20 A˚
duction. and c 133.48A˚, and contain four molecules of MK2 in the asymmet-
ric unit. Native MK2 was crystallized in the presence of ADP, and
the protein solution was prepared as above, except that 5 mM ADPPurification of MK2 41–364
The purification was performed at 4C. Five grams of bacterial cells was added, instead of the staurosporine. Diffraction quality native
MK2/ADP cocrystals were obtained at 18C from 2.0 M ammoniumwas homogenized in 200 ml of Buffer A (50 mM Tris [pH 7.5], 10
mM DTT, and 0.24 mg/ml AEBSF) plus 90 g/ml TPCK, 2.5 mM sulfate. These bipyramidal crystals belong to space group F4132,
with cell dimensions of a  b  c  253.05 A˚, and contain oneaminobenzamidine, and 500 l protease inhibitor cocktail for use
in purification of poly-(histidine)-tagged proteins (Sigma), RNase, molecule of MK2 and one molecule of ADP in the asymmetric unit.
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Data Collection, Phasing, and Refinement zation and likelihood ranking; status report and perspectives. Acta
Crystallogr. D Biol. Crystallogr. 54, 905–921.MK2—Staurosporine
A three-wavelength MAD phasing experiment was carried out on Bru¨nger, A.T., Adams, P.D., Clore, G.M., DeLano, W.L., Gros, P.,
beamline 5.0.2 at the ALS, Berkeley, using an ADSC Quantum-4 Grosse-Kunstleve, R.W., Jiang, J.S., Kuszewski, J., Nilges, M., and
CCD detector from a single crystal of SeMet-MK2 cooled to180C. Pannu, N.S. (1998). Crystallography and NMR system: a new soft-
All data were integrated and scaled with HKL2000 (Otwinowski and ware suite for macromolecular structure determination. Acta Crys-
Minor, 1997). The positions of the selenium atoms were determined tallogr. D Biol. Crystallogr. 54, 905–921.
in Shake and Bake (Weeks and Miller, 1999) and refined in SHARP
Carson, M. (1997). Ribbons. Methods Enzymol. 277, 493–505.(De La Fortelle and Bricogne, 1997) at 3.1 A˚ (Table 2). The structure of
CCP4 (1994). The CCP4 suite: programs for X-ray crystallography.the MK2 was built into the original 3.1 A˚-resolution solvent-flattened
Acta Crystallogr. D Biol. Crystallogr. 50, 760–763.symmetry-averaged MAD map with the X-AUTOFIT features within
QUANTA (Molecular Simulations, San Diego, CA). The phases were Clifton, A.D., Young, P.R., and Cohen, P. (1996). A comparison of
then extended from 3.1 A˚ to 2.7 A˚ with symmetry averaging in DM the substrate specificity of MAPKAP kinase-2 and MAPKAP
(CCP4, 1994). This model was then used as the initial model for kinase-3 and their activation by cytokines and cellular stress. FEBS
refinement with the program CNX (Brunger et al., 1998) against the Lett. 392, 209–214.
2.7 A˚ data. Prior to refinement, 5% of the data were randomly se-
Cuenda, A., Rouse, J., Doza, Y.N., Meier, R., Cohen, P., Gallagher,lected and designated as an Rfree test set to monitor the progress T.F., Young, P.R., and Lee, J.C. (1995). SB 203580 is a specificof the refinement. After seven cycles of refinement with REFMAC
inhibitor of a MAP kinase homologue which is stimulated by cellular(Murshudov et al., 1999) and rebuilding with QUANTA, refinement
stresses and interleukin-1. FEBS Lett. 364, 229–233.converged with a model that contained 4 molecules of MK2, 4 stau-
De La Fortelle, E., and Bricogne, G. (1997). Maximum-likelihoodrosporine molecules, 43 water molecules, and 2 sulfate ions at an
heavy atom parameter refinement and multiwavelength anomalousRcryst of 23.9% (Rfree of 27.4%). Of the four molecules of MK2 in the
diffraction methods. Methods Enzymol. 276, 472–494.asymmetric unit, molecule “C” was the most complete, with residues
41–153 and 227–357 visible in the electron density. The refinement Engel, K., Kotlyarov, A., and Gaestel, M. (1998). Leptomycin B-sensi-
statistics are given in Table 3. tive nuclear export of MAPKAP kinase 2 is regulated by phosphoryla-
MK2—ADP tion. EMBO J. 17, 3363–3371.
Single-wavelength (1.0 A˚) data for the MK2/ADP cocrystals were
Engel, K., Plath, K., and Gaestel, M. (1993). The MAP kinase-acti-
collected on beamline 5.0.1 at the ALS, Berkeley with an ADSC
vated protein kinase 2 contains a proline-rich SH3-binding domain.
Quantum-4 CCD detector from a single crystal cooled to 180C.
FEBS Lett. 336, 143–147.
The data were processed with HKL2000 (Otwinowski and Minor,
Engel, K., Schultz, H., Martin, F., Kotlyarov, A., Plath, K., Hahn, M.,1997), and the statistics are given in Table 2. The structure of the
Heinemann, U., and Gaestel, M. (1995). Constitutive activation ofMK2/ADP complex was solved by molecular replacement with a
mitogen-activated protein kinase-activated protein kinase 2 by mu-composite consisting of the overlapped MK2 monomers from the
tation of phosphorylation sites and an A-helix motif. J. Biol. Chem.staurosporine structure as the molecular replacement probe with
270, 27213–27221.AMORE (CCP4, 1994). The molecular replacement solution was then
rebuilt into a 3.2 A˚-resolution solvent-flattened map. After the initial Goldberg, J., Nairn, A.C., and Kuriyan, J. (1996). Structural basis for
placement of the protein chain into density, the model was rebuilt the autoinhibition of calcium/calmodulin-dependent protein kinase
with omit maps calculated with BUSTER (Bricogne, 1993) in order I. Cell 84, 875–887.
to eliminate any bias from the molecular replacement solution. The Hedges, J.C., Dechert, M.A., Yamboliev, I.A., Martin, J.L., Hickey,
structure was refined in CNX by the methods described above. E., Weber, L.A., and Gerthoffer, W.T. (1999). A role for p38MAPK/
Refinement converged after six rebuilding cycles, with an Rcryst of HSP27 pathway in smooth muscle cell migration. J. Biol. Chem. 274,
25.9% and an Rfree of 29.2%. The final model consisted of residues 24211–24219.
46–152, 159–217, 227–265, and 274–345 and the ADP moiety. The
Hendrickson, W.A. (1991). Determination of macromolecular struc-refinement statistics are given in Table 3.
tures from anomalous diffraction of synchrotron radiation. Science
254, 51–58.
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